Charles River [CRL] vs Icon plc [ICLR] Detailed Stock Comparison

Charles River Laboratories International, Inc.

NYSE
Loading...

Icon plc

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Charles River Laboratories International, Inc. wins in 4 metrics, Icon plc wins in 16 metrics, with 0 ties. Icon plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Charles River Laboratories International, Inc. Icon plc Better
P/E Ratio (TTM) 681.33 15.52 Icon plc
Price-to-Book Ratio 2.61 0.94 Icon plc
Debt-to-Equity Ratio 81.95 38.26 Icon plc
PEG Ratio 20.54 -0.16 Charles River Laboratories International, Inc.
EV/EBITDA 12.23 7.82 Icon plc
Profit Margin (TTM) -3.60% 7.40% Icon plc
Operating Margin (TTM) 4.51% 12.67% Icon plc
EBITDA Margin (TTM) 4.51% 12.67% Icon plc
Return on Equity -4.23% 6.27% Icon plc
Return on Assets (TTM) 4.24% 4.20% Charles River Laboratories International, Inc.
Free Cash Flow (TTM) $518.49M $1.12B Icon plc
1-Year Return 25.47% 0.36% Charles River Laboratories International, Inc.
Price-to-Sales Ratio (TTM) 2.06 1.11 Icon plc
Enterprise Value $10.72B $11.90B Icon plc
EV/Revenue Ratio 2.67 1.47 Icon plc
Gross Profit Margin (TTM) 31.15% 27.14% Charles River Laboratories International, Inc.
Revenue per Share (TTM) $81 $102 Icon plc
Earnings per Share (Diluted) $-2.90 $7.42 Icon plc
Beta (Stock Volatility) 1.62 1.28 Icon plc
Short % of Float 10.71% 3.82% Icon plc

Charles River Laboratories International, Inc. vs Icon plc Stock Performance Analysis

Loading Price Chart...

CRL
ICLR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Charles River Laboratories International, Inc.0.51%1.09%24.94%24.02%-4.89%-6.89%
Icon plc1.05%-2.97%26.93%51.34%-19.88%-21.70%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Charles River Laboratories International, Inc.25.47%-10.71%-46.99%128.42%379.20%406.37%
Icon plc0.36%-37.56%-31.10%128.30%504.05%1,004.91%

Performance & Financial Health Analysis: Charles River Laboratories International, Inc. vs Icon plc

MetricCRLICLR
Market Information
Market Cap i$8.28B$8.98B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i761,885968,191
90 Day Avg. Volume i865,618934,860
Last Close$188.47$147.72
52 Week Range$143.06 - $228.88$66.57 - $211.00
% from 52W High-17.66%-29.99%
All-Time High$460.21 (Sep 20, 2021)$347.72 (Jul 15, 2024)
% from All-Time High-59.05%-57.52%
Growth Metrics
Quarterly Revenue Growth-0.01%0.01%
Quarterly Earnings Growth-0.01%-0.99%
Financial Health
Profit Margin (TTM) i-0.04%0.07%
Operating Margin (TTM) i0.05%0.13%
Return on Equity (TTM) i-0.04%0.06%
Debt to Equity (MRQ) i81.9538.26
Cash & Liquidity
Book Value per Share (MRQ)$64.30$122.25
Cash per Share (MRQ)$4.34$6.14
Operating Cash Flow (TTM) i$737.65M$1.14B
Levered Free Cash Flow (TTM) i$572.38M$925.35M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Charles River Laboratories International, Inc. vs Icon plc

MetricCRL (Apr 24, 2026)ICLR (Apr 23, 2026)
Price Ratios
P/E Ratio (TTM) i681.3315.52
Forward P/E i13.599.42
PEG Ratio i20.54-0.16
Price to Sales (TTM) i2.061.11
Price to Book (MRQ) i2.610.94
Market Capitalization
Market Capitalization i$8.28B$8.98B
Enterprise Value i$10.72B$11.90B
Enterprise Value Metrics
Enterprise to Revenue i2.671.47
Enterprise to EBITDA i12.237.82
Risk & Other Metrics
Beta i1.621.28
Book Value per Share (MRQ) i$64.30$122.25

Financial Statements Comparison: Charles River Laboratories International, Inc. vs Icon plc

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCRL (2025)ICLR (2024)
Revenue/Sales i4.02B8.28B
Cost of Goods Sold i2.69B5.85B
COGS % of Revenue i67.0%70.6%
Gross Profit i1.32B2.44B
Gross Margin i33.0%29.4%
Research & Development iN/AN/A
Operating Income (EBIT) i401.14M1.22B
Operating Margin i10.0%14.7%
EBITDA i786.81M1.69B
EBITDA Margin i19.6%20.4%
Pre-Tax Income i-99.50M869.18M
Pre-Tax Income % of Revenue i-2.5%10.5%
Income Tax i42.66M77.71M
Income Tax % of Revenue i1.1%0.9%
Net Income (Profit) i-142.16M791.47M
Profit Margin i-3.5%9.6%

Balance Sheet & Liquidity Metrics

MetricCRL (2025)ICLR (2024)
Cash & Equivalents i213.77M538.79M
Total Current Assets i1.45B3.53B
Total Current Assets % of Revenue i36.0%42.6%
Total Current Liabilities i1.12B2.80B
Total Current Liabilities % of Revenue i27.9%33.8%
Long-Term Debt i2.57B3.54B
Long-Term Debt % of Revenue i64.0%42.7%
Total Shareholders Equity i3.21B9.52B
Retained Earnings i1.39B2.72B
Retained Earnings % of Revenue i34.6%32.9%
Property, Plant & Equipment i361.42M202.71M

Cash Flow Statement Comparison

MetricCRL (2025)ICLR (2024)
Operating Cash Flow i194.22M1.26B
Operating Cash Flow % of Revenue i4.8%15.3%
Capital Expenditures iN/A-168.06M
Free Cash Flow i518.49M1.12B
FCF Margin i12.9%13.5%
Debt Repayment i-1.35B-2.68B
Common Stock Repurchase i-360.67M-500.00M

Short Interest & Institutional Ownership Analysis

MetricCRLICLR
Shares Short i4.59M2.90M
Short Ratio i5.182.72
Short % of Float i10.71%3.82%
Shares Outstanding i49.22M76.36M
Float Shares i48.66M75.95M
% Held by Insiders i0.85%0.67%
% Held by Institutions i110.31%112.17%
% Held by Public i-11.16%-12.84%

Dividend Analysis & Yield Comparison: Charles River Laboratories International, Inc. vs Icon plc

MetricCRLICLR
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A